首页> 美国卫生研究院文献>Mediators of Inflammation >The TGF-β1 Signaling Pathway as an Attractive Target in the Fibrosis Pathogenesis of Sjögrens Syndrome
【2h】

The TGF-β1 Signaling Pathway as an Attractive Target in the Fibrosis Pathogenesis of Sjögrens Syndrome

机译:TGF-β1信号通路是干燥综合征综合征纤维化发病机制中的靶标。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Transforming growth factor β1 (TGF-β1) plays a crucial role in the induction of fibrosis, often associated with chronic phases of inflammatory diseases contributing to marked fibrotic changes that compromise normal organ function. The TGF-β1 signal exerts its biological effects via the TGF-β/SMAD/Snail signaling pathway, playing an important pathogenic role in several fibrotic diseases. It has as yet been poorly investigated in the chronic autoimmune disease Sjögren's syndrome (SS). Here, we firstly tested, by immunohistochemistry, whether the TGF-β1/SMAD/Snail signaling pathway is triggered in human pSS salivary glands (SGs). Next, healthy salivary gland epithelial cell (SGEC) cultures derived from healthy donors were exposed to TGF-β1 treatment, and the relative gene and protein levels of SMAD2/3/4, Snail, E-cadherin, vimentin, and collagen type I were compared by semiquantitative RT-PCR, quantitative real-time PCR, and Western blot analysis. We observed, both at gene and protein levels, higher expression of SMAD2, 3, and 4 and Snail in the SGEC exposed by TGF-β1 compared to untreated healthy SGEC. Additionally, in TGF-β1-treated samples, we found a significant reduction in the epithelial phenotype marker E-cadherin and an increase in the mesenchymal phenotype markers vimentin and collagen type I compared to those in untreated SGEC, indicating that TGF-β1 induces the EMT via the TGF-β1/SMAD/Snail signaling pathway. Therefore, by using the specific TGF-β receptor 1 inhibitor SB-431542 in healthy SGEC treated with TGF-β1, we showed a significant reduction of the fibrosis markers vimentin and collagen type I while the epithelial marker E-cadherin returns to levels similar to untreated healthy SGEC. These data demonstrate that TGF-β1 is an important key factor in the transition phase from SG chronic inflammation to fibrotic disease. Characteristic changes in the morphology and function of TGF-β1-treated healthy SGEC further confirm that TGF-β1 plays a significant role in EMT-dependent fibrosis.
机译:转化生长因子β1(TGF-β1)在诱导纤维化中起关键作用,纤维化通常与炎症性疾病的慢性期有关,从而导致明显的纤维化改变,损害了正常的器官功能。 TGF-β1信号通过TGF-β/ SMAD / Snail信号通路发挥其生物学作用,在多种纤维化疾病中起重要的致病作用。尚未对慢性自身免疫性疾病干燥综合征(SS)进行研究。在这里,我们首先通过免疫组织化学测试了人类pSS唾液腺(SGs)中是否触发了TGF-β1/ SMAD / Snail信号通路。接下来,将来自健康供体的健康唾液腺上皮细胞(SGEC)培养物进行TGF-β1处理,SMAD2 / 3/4,Snail,E-cadherin,波形蛋白和I型胶原的相对基因和蛋白质水平为通过半定量RT-PCR,定量实时PCR和Western blot分析进行比较。在基因和蛋白质水平上,我们观察到与未治疗的健康SGEC相比,TGF-β1暴露的SGEC中SMAD2、3和4和Snail的表达更高。此外,在TGF-β1处理的样本中,与未处理的SGEC相比,我们发现上皮表型标记E-钙粘着蛋白显着减少,间质表型标记波形蛋白和I型胶原蛋白增加,表明TGF-β1诱导了TGF-β1诱导通过TGF-β1/ SMAD / Snail信号通路进行EMT。因此,在健康的SGEC中使用TGF-β1受体1抑制剂SB-431542进行TGF- β 1处理后,我们发现纤维化标记波形蛋白和I型胶原明显减少,而上皮标记E-钙黏着蛋白恢复到与未治疗的健康SGEC相似的水平。这些数据表明,TGF-ββ 1是SG慢性炎症向纤维化疾病过渡时期的重要关键因素。 TGF- β 1处理的健康SGEC的形态和功能特征变化进一步证实,TGF- β 1在EMT依赖性纤维化中起重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号